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Type II Diabetes Mellitus (T2DM)
■ Global incidence: 425 million1
■ United States incidence: 30 million or 10.7% of the adult population
– 1.7 million new cases diagnosed each year2
■ Complications:
– Seventh leading cause of death in the US
– Cause of non-traumatic amputations of the lower extremities
– Blindness
– Permanent renal failure3
– Coronary risk equivalent and important cardiometabolic risk factor
1International
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Prediabetes
■ Prevalence: 35% of adults over the age of 20 and 50% of all adults over the
age of 651
■ Cost of T2DM in the US was estimated at $327 billion in 2017, an increase
of >5% per year from 20072
– By 2045, diabetes-related health expenditure will exceed $776 billion

■ Individuals with prediabetes may progress to diabetes at varying rates,
depending on genetic or environmental factors3
■ T2DM diagnosis is usually delayed around 4 to 7 years after disease onset
due to a lack of symptoms4
■ The American Diabetes Association estimated that up to 70% of individuals
with prediabetes will eventually progress to T2DM5
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Macro-level Reasons for T2DM Increase
■ Urbanization and environmental transitions
– Including vocation changes from heavy labor to sedentary
occupations
■ Increased technology
■ Improved transportation
■ Changes in food production, processing, and distribution

Popkin BM et al. Nutr Review

T2DM Prevention Goals
■ T2DM prevention could have an enormous impact on general
well-being and quality of life
■ Reduction of long-term morbidity and mortality
■ Decrease health care costs
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Physical Activity
■ The combination of excess weight and lack of PA is associated with T2DM1
■ Half of the U.S. adult population does not meet the recommended levels of 150
minutes per week of moderate intensity PA2
■ Studies have shown a strong inverse association between PA and the risk of
diabetes3
■ The American College of Sports Medicine, the Centers for Disease Control and
Prevention, the National Institutes of Health, and the U.S. Department of Health and
Human Services have concluded that routine moderate intense exercise was an
effective means to reduce the overall risk of chronic disease states
– Individuals should participate in at least 30 minutes of moderate intensity PA
on most if not all days of the week4
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Electronic PA Trackers
■ PA trackers improve on standard pedometers by providing automated feedback and
interactive behavior change tools via mobile device or personal computer
■ According to the Intercontinental Marketing Services (IMS) Institute for healthcare
informatics, as of 2015, there were 165,000 health related mobile phone apps on
android and iPhone operating systems with around 110,000 of these related to
health and fitness
■ Sales of wearable technology grew to almost $30 billion by 2017-2018
■ Technologies have the potential to give healthcare professionals better insight into
patients’ overall health and fitness patterns
– PA data can be aggregated with other healthcare data

IMS Health. http://www.theimsinstitute.org

Lifestyle Intervention Programs
■ Lifestyle intervention programs that focus on decreasing body weight and
increasing PA are effective at decreasing the risk of progression toward
T2DM
■ The ADA recommends that individuals with impaired glucose tolerance or
impaired fasting glucose should be referred to an on-going support program
for weight loss of 5 – 10% and increasing PA to at least 150 minutes per
week

Singh K et al. Can J Diabetes

Diabetes Prevention Program Results
■ Lifestyle intervention program
- 58% rate of reduction of
T2DM incidence
■ Metformin - 31% rate of
reduction of incidence
■ Every 1 kg reduction in weight
was an associated 16%
reduction of incidence

Diabetes Prevention Program - Group
Lifestyle Balance (DPP-GLB)
■ Originates from the DPP as a cost effective lifestyle intervention
■ Year-long program outcome goals remains the same as DPP:
– Weight loss of >7%
– PA attainment of 150 minutes of moderate intensity/week
■ The GLB program is unique, however, in its emphasis on group
sessions
■ Intervention requires intensive involvement of lifestyle coaches
■ Manual recordings of food intake, physical activity and weight

Study Summary
■ Little information about the feasibility of offering a lifestyle intervention with the
addition of technology to improve GLB program outcomes
■ Primary objective was to test the effects of a technology-based intervention that
utilized self-monitoring
– Primary outcomes: Attainment of 150 minutes of PA per week and weight loss
trending toward 7%.
– Secondary outcomes: Evaluation of percent body fat, blood pressure, waist
circumference, and body mass index
■ Hypothesis: Integrating technology into the GLB program would show improved
primary and secondary outcomes and would be more effective than the standard
GLB protocol at reducing the risk of T2DM

Participants
■ 40 years of age or older
■ BMI ≥24 kg/m2
■ No current or prior diagnosis of
diabetes
■ Had risk of developing diabetes
– History of gestational diabetes
– Score of ≥9 on the Centers for
Disease Control (CDC)
Prediabetes Screening Test
■ Completed PAR-Q form
■ 27% attrition rate (77% due to family
member needing extra care)
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Four Month Study
Baseline
Weeks 0-3
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GLB Control

Week 4

Weeks 4-15
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Study Groups
■ Control Group
– Met once weekly for 12 weeks
– Nutritional intake monitored
through Keeping Track
Booklets and the ‘CalorieKing’
– PA monitored through Keeping
Track Booklets and a
pedometer
– Received feedback once/week
via Keeping Track Booklets
■ Given one week after
booklets were turned in

■ Technology Group
– Met once weekly for 12 weeks
– Nutritional intake monitored
through MyFitnessPal app
– PA monitored through Fitbit
Flex
– Received feedback once/week
via SMS text message
■ Given mid-way through the
week
–

More likely to receive feedback

Data Collection
Continuous data collection

Data collected at weeks 0, 4, and 15

■ Weekly Weight

■ Height

■ Daily Steps

■ Weight

■ Weekly Minutes of PA

■ Blood Pressure

■ Daily Calories

■ Body Mass Index

■ Daily Fat Grams

■ % Body Fat
■ Waist Circumference
■ Patient Confidence Tool
Questionnaire

Weight Change
■ A generalized estimating equation (GEE) model was used to estimate average weight
lost
■ All participants lost 0.46 pounds/week
■ The technology group lost 17 pounds more over the study
■ 100% of technology participants lost weight
■ 73% of control participants lost weight
■ 7.7% of technology participants reached the 7% goal weight
■ 27.2% of control participants reached the 7% goal weight
■ Technology group lost an average of 7.35 pounds
■ Control group lost an average of 7.79 pounds

Body Mass Index Results
Baseline

End of Study

■ 21% Overweight
– Technology: 23%
– Control: 18%

■ 37% Overweight
– Technology: 38%
– Control: 36%

■ 79% Obese
– Technology: 77%
– Control: 82%

■ 63% Obese
– Technology: 62%
– Control: 64%

Physical Activity Change
■ 63% self-reported inactivity during the initial meeting
■ A GEE was conducted to test PA affects between technology and control
groups
■ Technology: decrease in PA of 114 minutes over 11 weeks compared to
control
■ Challenging to accurately assess PA change as objective and subjective
methods of measurement were used:
– The Fitbit Flex was used to objectively assess weekly minutes of PA
– The control group subjectively measured weekly minutes of PA through
self-monitoring

Data Collection Advantages
■ The Fitbit Flex technology allowed for collection of up to 77 days of PA
■ Technology: averaged PA tracking for 72.5 days
■ Control: averaged 47.7 days of PA tracking
■ Participants missed 12.8% of sessions
– Technology: 8.3%
– Control: 18.2%

PA Monitored by a Fitbit Flex
■ Baseline: 220.8 (SD = 249.0) minutes per week of moderate intensity PA
■ During the study, moderate intensity PA increased to 243.3 (SD = 198.8)
minutes per week
– This was not statistically significant with p = 0.631
– Considered to be clinically significant; moved into the PA time range for
promoting clinically significant weight loss
■ Baseline: 7511.6 steps/day (SD = 3271.2)
■ During study: increasing to 8177.6 steps/day (SD = 3078.9)
– The increase was not significant with p = 0.317

Weight Loss and PA Correlation
■ A Pearson Correlation Coefficient
showed a positive trend with
minutes of moderate-to-vigorous
activity and weight loss
■ The Pearson CC = 0.598 showing
a moderate association between
weight loss and minutes of PA
■ p = 0.031
■ R2 = 0.357
– About 36% of weight loss
was influenced by minutes of
PA

Fitbit Use
■ Compliance to wearing the Fitbit was very good with 93.1% of the
weeks having data tracked for at least ≥ 6 days/week
■ Of the 1415 tracked days, only 9.3% days recorded were of less than
2000 steps
■ Barriers were low:
– 84.6% had no smart phone issues
– 76.9% reported no technical difficulty with the tracker
– 92.3% had no issues with a lost/broken tracker

Technology Acceptance

Conclusions
■ Both groups were able to be successful with weight loss
– The addition of technology is not necessary for positive outcomes
■ All technology participants lost weight
■ Overall, control participants lost a greater amount of weight
■ Technology participants were more aware of activity and nutritional intake
– This did not translate into a greater amount of weight lost
■ Technology participants adhered well to wearing the Fitbit
■ Both groups showed a positive short-term effect on weight and BMI, which could be
interpreted as proxy of regression to T2DM

Limitations
■ This study was underpowered, which increases the potential for type II errors
■ We were limited by comparing the PA of the control group vs. the PA of the
technology group
– It is possible to compare the pedometer vs. Fitbit, however there are many
errors that take place when comparing weekly PA minutes tracked by the Fitbit
vs. self-tracking
■ Age range
■ Improvements are needed electronic monitoring methodologies for more accurate
measurements across various modalities of activities (e.g., cycling and water
activities)

Future Directions
■ Studies to assess populations for whom utilizing technology may be
inappropriate
– It is recommended that future studies research the effects of the aging
brain, to determine appropriateness when implementing technology with a
program
■ A blinded to activity study would be ideal. A PA tracking device other than the
Fitbit Flex may need to be utilized for this to occur
■ More research is needed to determine best practice when implementing through
a clinical setting.
– Integrating healthcare teams when using technology, could provide great
insight to the medical community in the prevention of not only diabetes, but
other disease states.
■ More recent literature has suggested monitoring various sphingolipids as
biomarkers of T2DM progression
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